{'fraction_non_alphanumeric': 0.015901060070671377, 'fraction_numerical': 0.0017667844522968198, 'mean_word_length': 5.831325301204819, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Bullous systemic contact dermatitis caused by an intra‐articular steroid injection

inducing cutaneous healing, with notable benefits on symptoms and quality of life. The discontinuance of such therapy produced quick recurrence of BPDCN lesions. Corticosteroidmediated effects both on immunological response and on IFN-1 production might have contributed to this result. In conclusion, systemic prednisone has been shown to be an alternative palliative, symptomatic treatment for a patient affected by cutaneous BPDCN and ineligible for any other aggressive therapy.